CDC's provisional surveillance through the week ending July 25 put Candida auris at 3,437 clinical
cases across 27 states this year, and health officials are pointing at nursing homes and other
settings caring for medically complex long-stay residents. Two days later the sector's largest
annual compensation survey landed, and the headline was not executive pay — it was MDS
coordinators, who took the biggest raises of any group in the building. Rehinged crossed both
against the scored facility base and found the same structure underneath each: the facilities
carrying the highest clinical and financial risk are the ones with the thinnest bench to manage it.
Why it matters for vendors: Both stories describe a market paying a premium for
scarce human expertise — infection preventionists on one side, assessment and coding specialists on
the other. Anything that substitutes for that expertise, extends it, or makes it portable is selling
into a line item that is visibly inflating. And the demand is not evenly spread: the 841 facilities
that score highest on infection prevention need average 2.09 stars, and the 195 facilities that
combine high penalty exposure with nursing turnover above 50% average 1.15 stars. These are not the
accounts most sales teams call first. They are the accounts with the problem.
Infection Prevention
Quality & Ratings
Candida auris reaches 3,437 cases in 27 states — and it is spreading toward the facilities with the thinnest infection-control bench
What happened
Provisional CDC surveillance through the week ending July 25 recorded 3,437 clinical cases
of Candida auris in 2026 across 27 states. California alone accounts for 873 of them,
roughly a quarter of the national total, with Texas next at 433, followed by Tennessee (283),
Ohio (279), Georgia (193), Louisiana (179), Illinois and Arizona (171 each), Nevada (166),
Michigan (146), Virginia (132) and Pennsylvania (121). Skilled Nursing News reported this week that
health officials are watching the drug-resistant fungus specifically in nursing homes and other
settings caring for medically complex residents, where it colonizes skin, persists on surfaces, and
resists both common antifungals and many routine cleaning agents. CDC classifies it as an urgent
antimicrobial resistance threat. The weekly counts are provisional and get revised as states
reconcile them, so treat the absolute numbers as a floor rather than a settled total.
Why it matters
C. auris is not a compliance abstraction — it is a colonization problem that travels with residents
between hospitals and skilled nursing facilities, which makes the SNF the place where transmission
either stops or compounds. That puts a specific set of vendors directly in the path of the story:
environmental hygiene and surface disinfection, admission screening and surveillance programs, PPE
and isolation supply, laboratory identification services, and contract or fractional infection
preventionist coverage. The commercial difficulty is that the facilities most exposed are also the
ones with the least capacity to run a rigorous program, which means the sale is rarely to an
informed buyer with a budget line waiting. It is a sale that has to create the budget line.
Rehinged scores infection prevention need across the 14,572 facilities with enough
underlying CMS data to support it, and the national average sits at 52.8. At the top of the
distribution, 841 facilities score 70 or above — the threshold at which the
demand signal is strong enough to act on. Those facilities are not a random slice of the industry.
They average 2.09 stars against 3.44 for the lowest-need group, carry 117 beds
against 96, and run nursing staff turnover of 47.9%. Across the country, 499 facilities are
currently carrying at least one citation from an infection control inspection, and those citations
total 1,139.
841
facilities at high infection-prevention need
2.09
average stars in that group
1,139
open infection-control citations nationally
Infection-control citations carried per facility
Highest-need facilities (score 70+)
1.38
Lowest-need facilities (score under 40)
0.49
Facilities scoring 70 or above on infection prevention need, leading states
The geography lines up with the outbreak in some states and diverges sharply in others, and the
divergence is the useful part. California is both the C. auris epicenter and the state with the
largest concentration of high-need facilities — 130 of its 1,165 SNFs, against 873 clinical cases.
Illinois, Michigan and Ohio show the same alignment at smaller scale. Nevada is the most
concentrated exposure in the country: 11 of its 66 nursing homes score 70 or above, one in six,
against 166 clinical cases in a state with fewer facilities than Ohio has in a single region.
Texas and Georgia run the other way. Texas has 1,177 facilities but only 14 score above 70 — yet
Texas facilities carry 207 infection-control citations, more than any other state,
against 433 clinical cases. Georgia has just 9 high-need facilities but 184 citations across 356
buildings, 2.36 per facility, the densest survey record in the country. In those
two states the citation history, not the composite score, is the buying signal. The sharpest list
of all is national and small: 91 facilities score 70 or above on infection prevention and
also carry weak staffing, and that group averages 1.6 stars, 130 beds, and 50.9% nursing
turnover — the largest buildings, the worst ratings, and half the nursing staff replaced every
year. Illinois holds 23 of those 91. Vendors selling disinfection systems, screening and
surveillance programs, and contract infection-preventionist coverage should work California,
Pennsylvania, Illinois and Michigan off the demand scores, and work Texas and Georgia off the
citation record instead.
Watch for: whether CDC's provisional weekly counts keep climbing through the fall as
states reconcile their reporting; whether state health departments begin issuing SNF-specific
screening or admission guidance, which would convert a clinical story into a procurement requirement;
and how infection control interacts with the risk-based survey process going national on
September 8 — harm-level citations from infection control inspections disqualify a facility from
the abbreviated survey track, which gives operators a dated, financial reason to fix the program.
Staffing
Reimbursement
MDS coordinators took the year's largest raises — the industry has decided documentation is a revenue function
What happened
The sector's largest annual salary and benefits survey, released Thursday by Hospital &
Healthcare Compensation Service, found that MDS coordinators posted a 4.25% average pay
increase in buildings that reported in both 2025 and 2026 — the largest gain of any group
in the organization, ahead of top-level executives. National average pay for the position reached
$93,302, and in the Pacific region the top-paid MDS group averaged more than
$125,000. Matt Leach, a principal at HCS partner Total Compensation Solutions, said the increase is
"directly related" to payment pressure: as documentation and coding accuracy drive reimbursement
under PDPM and state Medicaid case-mix systems, the person who owns the assessment owns the revenue.
Why it matters
Two forces are converging on the same role. Assessment accuracy determines payment, and it now also
determines survey standing — accurate data submission is one of the qualifying criteria for the
risk-based survey process taking effect nationally on September 8. That makes MDS capacity a
revenue-protection function and a compliance function at once, which is why the pay is moving.
For vendors, the arithmetic is unusually favorable: MDS software, coding audit and review services,
remote and interim MDS staffing, and Medicaid case-mix analytics all sell against a fully loaded
in-house cost that is rising 4.25% a year off a $93,302 base. When the alternative to a service
contract is recruiting a scarce specialist into a building that cannot keep one, the comparison
makes itself. The constraint is that the operators who most need the help are the ones with the
least ability to evaluate it.
Nursing staff turnover across the 13,543 facilities that report it averages
45.9% nationally. Nearly a third of the industry sits well above that:
4,824 facilities exceed 50% annual turnover and 2,105 exceed 60%. On the payment
side, Rehinged scores penalty risk on 6,576 facilities with sufficient enforcement history, and
340 of them score 70 or above, with another 1,940 in the elevated 40-to-69 band.
Crossing the two is where the commercial signal lives.
4,824
facilities above 50% nursing turnover
195
high penalty risk and 50%+ turnover
1.15
average stars in that group
Average annual nursing staff turnover, highest and lowest large states
Facilities running above 60% annual nursing staff turnover, leading states
The compensation data and the retention data are telling the same story from opposite ends.
California, where the Pacific MDS premium above $125,000 is concentrated, runs the lowest average
nursing staff turnover of any large state at 36.8%. Missouri, Oklahoma and Texas
all sit above 55%, and Texas alone has 341 facilities churning more than 60% of
their nursing staff every year — more than Ohio and Missouri combined. A Missouri operator paying
near the $93,302 national average is bidding for the same scarce assessment expertise as a
California operator paying a third more, and losing more than half its nursing staff annually
while doing it. That gap is the entire market for remote and interim MDS services, coding audits,
and assessment automation. The tightest target list is the 195 facilities that combine
high penalty exposure with turnover above 50% — averaging 1.15 stars and 134 beds, so
large buildings with real revenue at stake and no margin for a coding error. Illinois holds 66 of
them, a third of the national total, followed by Texas with 23 and Missouri and Wisconsin with 16
each. Vendors in MDS software, coding review, and interim assessment staffing should build the
fall territory plan around Illinois, Texas, Missouri, Ohio and Oklahoma, and lead with penalty
exposure rather than efficiency — the buyer in these buildings is protecting revenue, not
optimizing it.
Watch for: the full HCS report release, which will show whether the MDS premium is
broad or concentrated in a handful of high-cost markets; state Medicaid case-mix rebasing schedules,
which set the deadlines that make assessment accuracy urgent; and the September 8 risk-based survey
start, where accurate data submission becomes a published, quarterly-rechecked eligibility test
rather than an internal quality goal.